Barbara Ann Karmanos Cancer Hospital

“The sole member of barbara ann karmanos cancer hospital is the barbara ann karmanos cancer institute.”

“Barbara ann karmanos cancer institute, the sole member, has the power to recommend and nominate candidates for the barbara ann karmanos cancer hospital board of directors. The member may also remove directors.”

“Barbara ann karmanos cancer institute, sole member of barbara ann karmanos cancer hospital, has the power to approve any amendment of the articles of incorporation of the corporation and approve any amendment of the bylaws of the corporation. The sole member may also approve the merger, consolidation, dissolution, sale or other transfer of substantially all assets of barbara ann karmanos cancer hospital, or other change in corporate form.”

“The form 990 data is prepared internally and submitted to our auditing firm for return preparation. Once the returns have been completed, the forms are reviewed by entity cfo and the finance leadership of mclaren health care (mhc). Copies of draft returns are made available to the mhc board members, who serve as the overall governing board. Returns are available for all corporations of which mhc is the sole member as well as other related entities of those corporations for review rather than having the local boards review the returns. The board of mhc is the ultimate accountable organization for the system; as such it is the overall governing board of the system, whose responsibilities include but are not limited to: approving all subsidiary board members, financial budgets, and issuance of debt.”

“The corporate compliance department, in accordance with the mclaren health care (mhc) board conflict of interest policy, annually distributes the conflict of interest disclosure survey to all mhc corporate and subsidiary organization board members, executives and other leadership employees. The corporate compliance department through the governance committee, compiles and analyzes survey data by organization, investigates and reviews potential conflicts with the organization's ceo and board chair, and when necessary, recommends actions to be taken to resolve identified conflicts. A complete report of all corporate and subsidiary board member and executive disclosures, conflicts identified and actions taken is reviewed by the mhc governance committee and each subsidiary ceo and board chair receives a report specific to their organization's board members and executives. Conflicts are disclosed to the full board and board committees so appropriate actions can be taken. Actions may include prohibiting a board member from participating in deliberations involving transactions with a company with which they conduct financial transactions; board members failing to complete a disclosure survey or intentionally failing to report a known conflict of interest are relieved of their service to mhc.”

“The compensation committee is appointed by the board of directors to review the performance and recommend the total compensation package of the mclaren healthcare corporation's ceo to the board. Further the committee establishes the salary ranges and perquisites of the other most highly compensated officers (mhc executive & senior vice-presidents and ceos of mhc subsidiary organizations) to the board. The members of the committee must meet the independence requirements of the applicable provisions of section 4958 of the internal revenue code of 1986, as amended and final treasury regulations section 53.4958-6(c)(1)(iii). The committee retains the services annually of an independent firm with significant qualifications and experience to conduct a review of the corporation's executive compensation program. The retained firm utilizes appropriate compensation comparability data. The retained firm conducts analysis of the competitiveness of these programs and expresses an opinion to the reasonableness of these compensation programs. All data utilized by the committee, deliberations of the committee, and final compensation decisions by the committee are documented in formal reports and minutes. The corporate compensation committee works under and periodically renews the mclaren health care corporation compensation committee charter. The most recent year this process was undertaken was fiscal year 2024.”

“The barbara ann karmanos cancer hospital governing documents, conflict of interest statements and financial statements are available to the public upon request.”

“Purchased services - dmc & wsu: program service expenses 89,807,925. Management and general expenses 4,443,616. Fundraising expenses 0. Total expenses 94,251,541. Repairs and maintenance: program service expenses 2,225,909. Management and general expenses 0. Fundraising expenses 0. Total expenses 2,225,909. Clinical trials: program service expenses 16,951,493. Management and general expenses 218,388. Fundraising expenses 0. Total expenses 17,169,881. Other: program service expenses 7,245,950. Management and general expenses 13,370,395. Fundraising expenses 0. Total expenses 20,616,345.”

“Transfer to related parties -143,591,696. Adjustment for joint venture income recorded at cost per books -230,967.”

“This process has not changed from the prior year.”